Lung Cancer Brief Thomas Urban Marron, MD, PhD Icahn School of Medicine at Mount Sinai CRI Clinical Innovator Dr. Thomas Urban Marron, MD, PhD, stands as a notable figure in lung cancer research and treatment with the Icahn School of Medicine at Mount Sinai. His expertise in both medicine and research positions him as a distinguished authority in the field. Dr. Marron’s notable role as a CRI Clinical Innovator reflects his commitment to driving innovation in cancer immunotherapy. Through his work, he contributes significantly to advancing our understanding of lung cancer and developing novel approaches to treatment, marking him as a key influencer in the ongoing efforts to combat this complex disease. Dr. Marron’s dual role as a clinician and innovator underscores his dedication to bridging the gap between cutting-edge research and practical, patient-centered care in the realm of lung cancer. A Coffee for Your Thoughts? Take our Patient Immunotherapy Summit survey and enjoy a free coffee, on us! Take the Survey Patient Immunotherapy SummitFull Program (90 min) Immunotherapy 101: What is Immunotherapy and How Does it Work? I’m the Answer to Cancer™ Jeff’s Patient Story (Melanoma) Breast Cancer Brief I’m the Answer to Cancer™ Barry’s Patient Story (Lung Cancer) Ovarian Cancer Brief Pancreatic Cancer Brief Hot Topics and Trends in Cancer Immunotherapy A Coffee for Your Thoughts? Take our Patient Immunotherapy Summit survey and enjoy a free coffee, on us! Take the Survey